指南一致性诊疗在减轻宫颈癌保险状态差异中的作用
基于美国国家癌症数据库2004至2016年103,400例宫颈癌患者,评估指南一致性诊疗能否缩小医疗补助与无保险女性与私人保险者的生存差异。医疗补助与无保险患者接受循证治疗的比例更低、死亡风险更高;即使接受指南一致性诊疗,其死亡风险仍高于私人保险者。
要点
- 医疗补助与无保险宫颈癌患者较私人保险者死亡风险升高(aHR分别为1.36和1.29)。
- 医疗补助与无保险患者接受指南一致性诊疗后死亡风险仍高于私人保险者(aHR分别为1.38和1.24)。
- 接受质量诊疗并未消除宫颈癌患者基于保险状态的生存差异。
核心结论
- 医疗补助与无保险患者在各分期接受循证治疗的可能性更低且死亡风险更高,接受质量诊疗并未消除基于保险状态的差异。
研究设计与样本
- 利用美国国家癌症数据库识别2004至2016年接受治疗的宫颈癌女性,确定8项质量指标,按保险状态和分期分层分析生存结局。
- 共识别103,400例患者,其中47.0%有私人保险,21.5%为医疗补助,9.2%无保险。
主要发现
- 医疗补助与无保险患者较私人保险者显著更少及时完成放疗和及时启动治疗,无保险患者也显著更少接受局部晚期疾病治疗。
- 医疗补助与无保险患者较私人保险者更少接受淋巴结评估和初始放化疗。
- 医疗补助与无保险患者较私人保险者死亡风险升高(aHR=1.36,95%CI 1.31-1.41;aHR=1.29,95%CI 1.23-1.36)。
- 接受指南一致性诊疗的医疗补助与无保险患者较私人保险者死亡风险仍升高(aHR=1.38,95%CI 1.35-1.49;aHR=1.24,95%CI 1.16-1.32)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether the receipt of evidence-based care could mitigate survival disparities among Medicaid recipients and uninsured women with cervical cancer. METHODS: The National Cancer Database was utilized to identify women with cervical cancer treated from 2004 to 2016. Eight quality metrics were determined. Survival outcomes were examined stratified by insurance status and stage. To measure the impact of guideline-concordant care on the mitigation of disparities, we compared survival outcomes of the overall cohort to one that was perfectly adherent to all quality metrics. RESULTS: A total of 103,400 patients were identified; 47.0% of patients had private insurance, 21.5% Medicaid and 9.2% uninsured. Medicaid and uninsured patients were significantly less likely than privately insured patients to receive timely completion of radiation and timely initiation of treatment; uninsured patients were also significantly less likely to receive treatment for locally advanced disease. Medicaid and uninsured patients were also less likely to receive lymph node assessment and primary chemoradiation. Medicaid and uninsured patients had an increased risk of mortality compared to privately insured patients (aHR = 1.36, 95% CI 1.31-1.41 and aHR 1.29, 95% CI 1.23-1.36 respectively). While the receipt of these quality metrics was associated with improved survival, Medicaid and uninsured women who received guideline-concordant care were still at an increased risk of death compared to women with private insurance (aHR = 1.38, 95% CI 1.35-1.49 and aHR = 1.24; 95% CI, 1.16-1.32 respectively). CONCLUSION: Medicaid and uninsured patients were less likely to receive evidence-based care and were at increased risk of mortality at all stages compared to privately insured patients. The receipt of quality care does not eliminate insurance status-based disparities among women with cervical cancer.
引用
- Wu J, Huang Y, Tergas AI, et al. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer. Gynecol Oncol. 2020. PMID: 32800656. doi:10.1016/j.ygyno.2020.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。